Axsome Therapeutics, Inc. (AXSM)
156.92
-1.96
(-1.23%)
USD |
NASDAQ |
Mar 20, 16:00
156.87
-0.05
(-0.03%)
After-Hours: 20:00
Axsome Therapeutics Research and Development Expense (Quarterly) : 48.68M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 64.86M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| Vanda Pharmaceuticals, Inc. | 29.01M |
| Amicus Therapeutics, Inc. | 23.74M |